Clinical Case Reports (May 2021)
A case series of serious and unexpected adverse drug reactions under treatment with cariprazine
- Johannes Heck,
- Johanna Seifert,
- Dirk O. Stichtenoth,
- Christoph Schroeder,
- Adrian Groh,
- Gregor R. Szycik,
- Detlef Degner,
- Ivana Adamovic,
- Michael Schneider,
- Catherine Glocker,
- Eckart Rüther,
- Stefan Bleich,
- Renate Grohmann,
- Sermin Toto
Affiliations
- Johannes Heck
- Institute for Clinical Pharmacology Hannover Medical School Hannover Germany
- Johanna Seifert
- Department of Psychiatry Social Psychiatry and Psychotherapy Hannover Medical School Hannover Germany
- Dirk O. Stichtenoth
- Institute for Clinical Pharmacology Hannover Medical School Hannover Germany
- Christoph Schroeder
- Institute for Clinical Pharmacology Hannover Medical School Hannover Germany
- Adrian Groh
- Department of Psychiatry Social Psychiatry and Psychotherapy Hannover Medical School Hannover Germany
- Gregor R. Szycik
- Department of Psychiatry Social Psychiatry and Psychotherapy Hannover Medical School Hannover Germany
- Detlef Degner
- Department of Psychiatry and Psychotherapy Georg August University of Göttingen Göttingen Germany
- Ivana Adamovic
- Department of Psychiatry and Psychotherapy Georg August University of Göttingen Göttingen Germany
- Michael Schneider
- University Clinic for Psychiatry and Psychotherapy Brandenburg Medical School Immanuel Klinik Rüdersdorf Germany
- Catherine Glocker
- Department of Psychiatry and Psychotherapy Ludwig Maximilian University of Munich Munich Germany
- Eckart Rüther
- Department of Psychiatry and Psychotherapy Ludwig Maximilian University of Munich Munich Germany
- Stefan Bleich
- Department of Psychiatry Social Psychiatry and Psychotherapy Hannover Medical School Hannover Germany
- Renate Grohmann
- Department of Psychiatry and Psychotherapy Ludwig Maximilian University of Munich Munich Germany
- Sermin Toto
- Department of Psychiatry Social Psychiatry and Psychotherapy Hannover Medical School Hannover Germany
- DOI
- https://doi.org/10.1002/ccr3.4084
- Journal volume & issue
-
Vol. 9,
no. 5
pp. n/a – n/a
Abstract
Abstract Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.
Keywords
- adverse drug reactions
- cariprazine
- dopamine supersensitivity psychosis
- drug safety
- hyperprolactinemia
